|
|
|
Volumn 34, Issue 12 SUPPL., 1996, Pages
|
|
Update and evaluation of Australian guidelines: Industry perspective
|
|
Author keywords
Drug regulation; Guidelines, pharmaceuticals; Product development
|
|
Indexed keywords
ARTICLE;
AUSTRALIA;
COST BENEFIT ANALYSIS;
DRUG APPROVAL;
DRUG INDUSTRY;
ECONOMICS;
HEALTH CARE COST;
HUMAN;
ORGANIZATION AND MANAGEMENT;
PRACTICE GUIDELINE;
TREATMENT OUTCOME;
AUSTRALIA;
COST-BENEFIT ANALYSIS;
DRUG APPROVAL;
DRUG INDUSTRY;
GUIDELINES;
HEALTH EXPENDITURES;
HUMANS;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
|
|
EID: 0030331487
PISSN: 00257079
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (1)
|
